Literature DB >> 28607038

WHO downgrades oseltamivir on drugs list after reviewing evidence.

Zosia Kmietowicz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28607038     DOI： 10.1136/bmj.j2841

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.

Authors:  Kai-Cheng Hsu; Hui-Chen Hung; Wei-Chun HuangFu; Tzu-Ying Sung; Tony Eight Lin; Ming-Yu Fang; I-Jung Chen; Nikhil Pathak; John T-A Hsu; Jinn-Moon Yang
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

Review 2.  Drugs for Influenza Treatment: Is There Significant News?

Authors:  Nicola Principi; Barbara Camilloni; Anna Alunno; Ilaria Polinori; Alberto Argentiero; Susanna Esposito
Journal:  Front Med (Lausanne)       Date:  2019-05-28

3.  Assessment of Temporal Patterns and Patient Factors Associated With Oseltamivir Administration in Children Hospitalized With Influenza, 2007-2020.

Authors:  Patrick S Walsh; David Schnadower; Yin Zhang; Sriram Ramgopal; Samir S Shah; Paria M Wilson
Journal:  JAMA Netw Open       Date:  2022-09-01

4.  Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza.

Authors:  Naomi Bradbury; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  BMC Health Serv Res       Date:  2018-05-02       Impact factor: 2.655

5.  Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol.

Authors:  Emily Bongard; Alike W van der Velden; Johanna Cook; Ben Saville; Philippe Beutels; Rune Munck Aabenhus; Curt Brugman; Slawomir Chlabicz; Samuel Coenen; Annelies Colliers; Melanie Davies; Muireann De Paor; An De Sutter; Nick A Francis; Dominik Glinz; Maciek Godycki-Ćwirko; Herman Goossens; Jane Holmes; Margareta Ieven; Menno de Jong; Morten Lindbaek; Paul Little; Frederico Martinón-Torres; Ana Moragas; József Pauer; Markéta Pfeiferová; Ruta Radzeviciene-Jurgute; Pär-Daniel Sundvall; Antoni Torres; Pia Touboul; Dionyssios Varthalis; Theo Verheij; Christopher C Butler
Journal:  BMJ Open       Date:  2018-07-12       Impact factor: 2.692

6.  Rate of use and effectiveness of oseltamivir in the treatment of influenza illness in high-risk populations: A systematic review and meta-analysis.

Authors:  So-Jung Shim; Mei Chan; Louisa Owens; Adam Jaffe; Bernadette Prentice; Nusrat Homaira
Journal:  Health Sci Rep       Date:  2021-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.